These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14981872)

  • 1. Egg beaters. Flu vaccine makers look beyond the chicken egg.
    Hopkin K
    Sci Am; 2004 Mar; 290(3):16, 18. PubMed ID: 14981872
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of sindbis, influenza, and vesicular stomatitis viruses in chicken embryo and rat embryo cell suspensions.
    Keay L; Schlesinger S
    Biotechnol Bioeng; 1974 Aug; 16(8):1025-44. PubMed ID: 4371703
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.
    Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Dorner F
    Vaccine; 1998; 16(9-10):960-8. PubMed ID: 9682344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth cycle of influenza as studied in touch preparations of the allantoic layer of chick embryos. 1. The number of cells lining the allantoic cavity.
    Cuadra M
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):393-420. PubMed ID: 1237205
    [No Abstract]   [Full Text] [Related]  

  • 5. Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.
    Hughes K; Zachertowska A; Wan S; Li L; Klimaszewski D; Euloth M; Hatchette TF
    Vaccine; 2007 May; 25(22):4456-63. PubMed ID: 17418461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reproduction of influenza viruses in the tissue culture of chorioallantoic membrane of chick embryos attached to the egg shell].
    Mal'tseva AI; Agranovskaia EN; Zelichenok IuM; Shvartsman IaS
    Lab Delo; 1973; 11():689-90. PubMed ID: 4132578
    [No Abstract]   [Full Text] [Related]  

  • 7. [Improvement of the preparation of anti-influenza donor gamma-globulin. Report 1. Experience in the cultivation of the killed influenza vaccine, purified and concentrated by means of gradient centrifugation].
    Sokolov NN; Zhukova TIa; Malafeeva LK; Geft RA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():74-7. PubMed ID: 4143404
    [No Abstract]   [Full Text] [Related]  

  • 8. Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines).
    Doroshenko A; Halperin SA
    Expert Rev Vaccines; 2009 Jun; 8(6):679-88. PubMed ID: 19485748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response.
    Carvajal-Yepes M; Sporer KR; Carter JL; Colvin CJ; Coussens PM
    Hum Vaccin Immunother; 2015; 11(9):2296-304. PubMed ID: 26090991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLOOD GROUP A-LIKE SUBSTANCES IN EMBRYONATED CHICKEN EGGS AND THEIR RELATION TO EGG-GROWN INFLUENZA VIRUSES.
    SPRINGER GF; TRITEL H
    Bibl Haematol; 1964; 19():771-5. PubMed ID: 14267109
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of hydrocortisone on growth in embryonated chicken egg of influenza virus A2/Hong Kong/68].
    Frezza G; Miluccio V; Verde F; Visconti M
    Boll Soc Ital Biol Sper; 1974 May; 50(9):589-94. PubMed ID: 4447754
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation.
    Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M
    J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylaxis from the influenza virus vaccine.
    Coop CA; Balanon SK; White KM; Whisman BA; Rathkopf MM
    Int Arch Allergy Immunol; 2008; 146(1):85-8. PubMed ID: 18087166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based vaccines yield only modest advances for seasonal flu.
    Willyard C
    Nat Med; 2013 Jan; 19(1):4. PubMed ID: 23295991
    [No Abstract]   [Full Text] [Related]  

  • 15. Surface properties of the egg and mouse lines of A1 influenza virus.
    Borecký L; Lackovic V; Rathová V
    J Immunol; 1965 Aug; 95(2):387-95. PubMed ID: 5838760
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine manufacture at the time of a pandemic influenza.
    Chalumeau HP
    Eur J Epidemiol; 1994 Aug; 10(4):487-90. PubMed ID: 7843364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.
    Minor PD; Engelhardt OG; Wood JM; Robertson JS; Blayer S; Colegate T; Fabry L; Heldens JG; Kino Y; Kistner O; Kompier R; Makizumi K; Medema J; Mimori S; Ryan D; Schwartz R; Smith JS; Sugawara K; Trusheim H; Tsai TF; Krause R
    Vaccine; 2009 May; 27(22):2907-13. PubMed ID: 19366582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth properties of influenza virus type C.
    Prasad AK; Czekalowski JW
    Indian J Pathol Microbiol; 1975 Jul; 18(3):168. PubMed ID: 1240093
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on influenza virus type C.
    Prasad AK; Czekalowski JW
    J Med Microbiol; 1970 Feb; 3(1):Pxi. PubMed ID: 5448894
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant influenza-virus vaccines: I. Rapid derivation and preliminary characterization of high-yielding recombinants of influenza virus.
    Higashihara M; Igarashi Y; Nakagawa S; Saito Y
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):1-26. PubMed ID: 1025339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.